Verona Pharma plc (VRNA) Tops Q2 EPS by 2c

Verona Pharma plc (NASDAQ: VRNA) reported Q2 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• MotorK names Roy Toren to board as Helen Protopapas resigns
• Bending Spoons closes IPO, raises ~$954M on Nasdaq